Our results demonstrate that AS-IV may decrease MAP4K3 expression by regulating H3K4me1 binding, which may be one of the potential mechanisms that AS-IV plays a protective effect on DN. The gene discussed is MAP4K3; the disease is liver dysplastic nodule.